Refeyn Harnesses Power of Mass Photometry for Drug Discovery Research
Refeyn developed macro mass photometry, a new technology that builds on the principles of mass photometry, for the analysis of large viral vectors. Both mass photometry and macro mass photometry are opening up new possibilities for bioanalytics and research into the functions of biomolecules, explains Gabriella Kiss, Director-Regulatory Strategy and Engagement, Refeyn in her latest interaction with Pharma Industrial India.
Software Module | 12/12/2024
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy